Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

81 results
Display

Two Cases of Discontinuation Syndrome Following Cessation of Cholinesterase Inhibitors

Kwak YT

  • KMID: 2343089
  • J Korean Neurol Assoc.
  • 2004 Aug;22(4):386-388.
Discontinuation syndrome is a cluster of symptoms that appear when a patient terminates long-term medication. We report 2 patients with Alzheimer's disease who developed significant behavioral disturbances after the cessation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacological Treatment of Dementia

Hahn SJ, Paik NJ

Pharmacological interventions are critical in dementia treatment to prevent disease progression. In this review, we aim to summarize and discuss about the current developments and recommendations in the pharmacological treatment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Characteristics of Dementia with Lewy Bodies

Cheon JS, Chiu E

  • KMID: 2064042
  • J Korean Geriatr Psychiatry.
  • 2001 Jun;5(1):36-46.
The dementia with Lewy bodies which was common next to the Alzheimer's dementia had been oftenly misdiagnozed as vascular dementia. The pathologic diagnosis of dementia with Lewy bodies was increasing...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Delusions in Alzheimer's Disease

Kwak YT, Yang Y, Koo MS

Alzheimer's disease (AD) is associated with cognitive and functional impairment as well as neuropsychiatric complications, including psychotic symptoms such as delusions and hallucinations. Recent studies strongly suggest that delusions should...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacological Treatment of Alzheimer's Disease

Lee JH

  • KMID: 2053698
  • Hanyang Med Rev.
  • 2006 Feb;26(1):26-32.
The current treatment of Alzheimer's disease (AD) is based on symptomatic pharmacological therapy of cognitive decline and behavioural disturbance. A number of therapies have been investigated for the treatment and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evidence-Based Treatment of Alzheimer's Disease

Lee DW, Huh YS, Kim KW

The pharmacological treatment of Alzheimer's disease is based on symptomatic therapy of cognitive decline and behavioral problems. Numerous therapies have been investigated for the treatment and prevention of Alzheimer's disease....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case with Ophthalmoplegia Following Snake Bite

Min JH, Do HS, Hong SW, Han SK, Kim IS, Ryu S, Kim SW, Yoo IS

  • KMID: 2331478
  • J Korean Soc Emerg Med.
  • 2006 Oct;17(5):509-511.
Ophthalmoplegia following snake bite is a rare but not serious neurotoxic complication. However, symptoms like diplopia, blurred vision, and ocular discomfort can be emotionally devastating for a patient. We experienced...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Bilateral Oculomotor Nerve Palsy after Snake Bite

Sohn EH, Choi SY, Kim DH, Kim J, Kim JM, Lee AY

  • KMID: 2343276
  • J Korean Neurol Assoc.
  • 2007 Aug;25(3):440-441.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hypersexuality in Dementia

Cheon JS

  • KMID: 2186208
  • J Korean Geriatr Psychiatry.
  • 2003 Jun;7(1):76-82.
PURPOSE: Hypersexual behavior such as increased libido, change in sexual orientation or disinhibition had been reported in dementia. Mechanism and treatment measures were reviewed. METHOD: A medline search was undertaken...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Drug Therapy for Alzheimer's Disease

Suh GH

Alzheimer's disease (AD) is the most common cause of dementia in the elderly. AD afflicts 0.3 to 0.5 million people in Korea, and the number is projected to increase to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Antiallodynic Effects between Intrathecal Cholinesterase Inhibitors and NMDA Antagonists on Two Neuropathic Pain Rat Models

Kang KN, Cho SJ, Hwang JH

BACKGOUND: Cholinesterase inhibitors and N-methyl-D-aspartate (NMDA) antagonists reduce the mechanical allodynia in neuropathic pain models. In this study our aim was to compare the antiallodynic effects between intrathecal cholinesterase inhibitors...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of Ethanol on Cholinesterase Inactivation by Organophosphorous

Choi HC, Kim JH, Ha JH, Lee KY, Kim WJ, Woo HJ, Huh CU, Son SM, Chun EJ

  • KMID: 2320290
  • Yeungnam Univ J Med.
  • 1999 Dec;16(2):326-332.
BACKGROUND: In korea the agricultural community widely uses organophosphorous, and organophosphorous poisonings are increasing every year. We compared change in activity of acetylcholinesterase and pseudocholinesterase by organophosphorous and by the interaction...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Vascular Dementia: A Comprehensive Review

Lee JH

  • KMID: 2343052
  • J Korean Neurol Assoc.
  • 2003 Oct;21(5):445-454.
Vascular dementia (VaD) is the second most common cause of dementia in the elderly after Alzheimer's disease. At present, there are only very limited data that might support either the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Health Effects Induced by Non-occupational Exposure to Pesticides

Moon JD

  • KMID: 1973079
  • Chonnam Med J.
  • 1996 Jun;32(1):79-88.
In order to evaluate possible health effects of the exposure to pesticide on health, 100 exposed subjects from the community surrounded by the cotton field exposed to pesticide and 100...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vascular Dementia

Lee AY

Cerebrovascular disease is the second leading cause of cognitive impairment in the elderly, either alone or in combination with Alzheimer's disease (AD). Vascular dementia (VaD) is heterogeneous in terms of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vascular Dementia

Lee YM, Kim E, Park JM

  • KMID: 2137455
  • J Korean Geriatr Psychiatry.
  • 2012 Dec;16(2):82-88.
Vascular dementia (VaD) is a dementia syndrome produced by vascular damage to the brain and increases in incidence with advancing age. Early Identification and diagnosis of VaD is particularly importent...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Features and Pharmacological Treatment of Dementia with Lewy Bodies

Kim TH

Dementia with Lewy bodies (DLB) is the second most common causes of dementia. It can exhibit a variety of clinical symptoms including cognitive decline, cognitive fluctuation, visual hallucinations, parkinsonism, REM...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vascular Dementia

Kim TW, Kwak KP

Vascular dementia is a very frequent form of dementia. Debates over classification and diagnostic criteria, and controversy over identifiable treatment targets will continue until distinct pathophysiological mechanism of vascular dementia...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent Advances in Diagnosis and Treatment of Alzheimer's Disease

Lee JJ, Lee SB

Alzheimer's disease (AD) is a neurodegenerative disorder in which neuronal loss causes cognitive decline and other neuropsychiatric problems. It can be diagnosed based on history, examination, and appropriate objective assessments,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Garcinexanthone G, a Selective Butyrylcholinesterase Inhibitor from the Stem Bark of Garcinia atroviridis

Khaw KY, Murugaiyah V, Khairuddean M, Tan WN

The present study was undertaken to investigate the isolated compounds from the stem bark of Garcinia atroviridis as potential cholinesterase inhibitors and the ligand-enzyme interactions of selected bioactive compounds in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr